Potential unmet need for gout diagnosis and treatment: capture―recapture analysis of a national administrative dataset
To estimate the degree of undercount of people diagnosed with gout in administrative datasets using capture-recapture methods. Hospitalization and drug dispensing claims (allopurinol or colchicine) data for all Aotearoa New Zealand were used to estimate the prevalence of gout in 2009 (n = 4 295 296)...
Gespeichert in:
Veröffentlicht in: | Rheumatology (Oxford, England) England), 2012-10, Vol.51 (10), p.1820-1824 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1824 |
---|---|
container_issue | 10 |
container_start_page | 1820 |
container_title | Rheumatology (Oxford, England) |
container_volume | 51 |
creator | JACKSON, Gary WRIGHT, Craig THORNLEY, Simon TAYLOR, William J KARU, Leanne Te GOW, Peter J ARROLL, Bruce GRIBBEN, Barry DALBETH, Nicola WINNARD, Doone |
description | To estimate the degree of undercount of people diagnosed with gout in administrative datasets using capture-recapture methods.
Hospitalization and drug dispensing claims (allopurinol or colchicine) data for all Aotearoa New Zealand were used to estimate the prevalence of gout in 2009 (n = 4 295 296). As a comparison, we calculated gout prevalence using a large primary care dataset using general practitioner diagnosis and prescribing records (n = 555 313). For each of these datasets, we estimated the undercount through capture-recapture analysis using a Poisson regression model. A two-list model was used, which included covariates such as age, gender, ethnic groups and New Zealand deprivation quintiles.
The crude prevalence of diagnosed gout in the Aotearoa New Zealand population aged ≥ 20 years was 3.75%. The covariate-adjusted capture-recapture estimate of those not recorded but likely to have gout was 0.92%, giving an overall estimated prevalence of 4.67% (95% CI 4.49, 4.90%) for the population aged ≥ 20 years. This amounts to 80% of people with gout being identified by the algorithm for the Aotearoa New Zealand data-that is being recorded in either lists of dispensing of allopurinol or colchicine or hospital discharge. After capture-recapture, gout prevalence for all males aged ≥ 20 years was 7.3% and in older (≥ 65 years) Māori and Pacific men was >30%.
Capture-recapture analysis of administrative datasets provides a readily available method for estimating an aspect of unmet need in the population-in this instance potentially 20% of those with gout not being identified and treated specifically for this condition. |
doi_str_mv | 10.1093/rheumatology/kes147 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1074771338</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1074771338</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-30a14579e0862aefa848f6c38ff0137ebb066aa6447ee3951ba2ae65899955b63</originalsourceid><addsrcrecordid>eNpN0M1O3DAQB3CrKuoC7RNUqnypxGVZO3bshBtC5UNaqRzgHE2S8daQ2FvbqdhbX4IX7JNgtMuW04xGv5mR_oR85eyUs1oswi-cRkh-8KvN4hEjl_oDOeRSFXMmRPFx3xdyRo5ifGCMlVxUn8isKHQhyro8JE-3PqFLFgY6uRETdYg9NT7QlZ8S7S2snI82UnA9TQEhjZmf0Q7WaQr47-9zwF2fCQybV-sNBeogWZ8nFPrROhtTyIM_SHtIEDF9JgcGhohfdvWY3F_-uLu4ni9_Xt1cnC_nnVAszQUDLktdI6tUAWigkpVRnaiMYVxobFumFICSUiOKuuQtZKbKqq7rsmyVOCYn27vr4H9PGFMz2tjhMIBDP8WGMy215kJUmYot7YKPMaBp1sGOEDYZNa-RN-8jb7aR561vuwdTO2K_33nLOIPvOwCxg8EEcJ2N_52SXNSVFi_THZI-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1074771338</pqid></control><display><type>article</type><title>Potential unmet need for gout diagnosis and treatment: capture―recapture analysis of a national administrative dataset</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>JACKSON, Gary ; WRIGHT, Craig ; THORNLEY, Simon ; TAYLOR, William J ; KARU, Leanne Te ; GOW, Peter J ; ARROLL, Bruce ; GRIBBEN, Barry ; DALBETH, Nicola ; WINNARD, Doone</creator><creatorcontrib>JACKSON, Gary ; WRIGHT, Craig ; THORNLEY, Simon ; TAYLOR, William J ; KARU, Leanne Te ; GOW, Peter J ; ARROLL, Bruce ; GRIBBEN, Barry ; DALBETH, Nicola ; WINNARD, Doone</creatorcontrib><description>To estimate the degree of undercount of people diagnosed with gout in administrative datasets using capture-recapture methods.
Hospitalization and drug dispensing claims (allopurinol or colchicine) data for all Aotearoa New Zealand were used to estimate the prevalence of gout in 2009 (n = 4 295 296). As a comparison, we calculated gout prevalence using a large primary care dataset using general practitioner diagnosis and prescribing records (n = 555 313). For each of these datasets, we estimated the undercount through capture-recapture analysis using a Poisson regression model. A two-list model was used, which included covariates such as age, gender, ethnic groups and New Zealand deprivation quintiles.
The crude prevalence of diagnosed gout in the Aotearoa New Zealand population aged ≥ 20 years was 3.75%. The covariate-adjusted capture-recapture estimate of those not recorded but likely to have gout was 0.92%, giving an overall estimated prevalence of 4.67% (95% CI 4.49, 4.90%) for the population aged ≥ 20 years. This amounts to 80% of people with gout being identified by the algorithm for the Aotearoa New Zealand data-that is being recorded in either lists of dispensing of allopurinol or colchicine or hospital discharge. After capture-recapture, gout prevalence for all males aged ≥ 20 years was 7.3% and in older (≥ 65 years) Māori and Pacific men was >30%.
Capture-recapture analysis of administrative datasets provides a readily available method for estimating an aspect of unmet need in the population-in this instance potentially 20% of those with gout not being identified and treated specifically for this condition.</description><identifier>ISSN: 1462-0324</identifier><identifier>ISSN: 1462-0332</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/kes147</identifier><identifier>PMID: 22723595</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Allopurinol - therapeutic use ; Biological and medical sciences ; Colchicine - therapeutic use ; Databases, Factual ; Diseases of the osteoarticular system ; Female ; Gout - diagnosis ; Gout - drug therapy ; Gout - epidemiology ; Gout Suppressants - therapeutic use ; Humans ; Inflammatory joint diseases ; Male ; Medical sciences ; Metabolic diseases ; Middle Aged ; Miscellaneous. Osteoarticular involvement in other diseases ; New Zealand - epidemiology ; Other metabolic disorders ; Prevalence ; Purines and pyrimidines (gout, hyperuricemia...) ; White People</subject><ispartof>Rheumatology (Oxford, England), 2012-10, Vol.51 (10), p.1820-1824</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-30a14579e0862aefa848f6c38ff0137ebb066aa6447ee3951ba2ae65899955b63</citedby><cites>FETCH-LOGICAL-c360t-30a14579e0862aefa848f6c38ff0137ebb066aa6447ee3951ba2ae65899955b63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26413987$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22723595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>JACKSON, Gary</creatorcontrib><creatorcontrib>WRIGHT, Craig</creatorcontrib><creatorcontrib>THORNLEY, Simon</creatorcontrib><creatorcontrib>TAYLOR, William J</creatorcontrib><creatorcontrib>KARU, Leanne Te</creatorcontrib><creatorcontrib>GOW, Peter J</creatorcontrib><creatorcontrib>ARROLL, Bruce</creatorcontrib><creatorcontrib>GRIBBEN, Barry</creatorcontrib><creatorcontrib>DALBETH, Nicola</creatorcontrib><creatorcontrib>WINNARD, Doone</creatorcontrib><title>Potential unmet need for gout diagnosis and treatment: capture―recapture analysis of a national administrative dataset</title><title>Rheumatology (Oxford, England)</title><addtitle>Rheumatology (Oxford)</addtitle><description>To estimate the degree of undercount of people diagnosed with gout in administrative datasets using capture-recapture methods.
Hospitalization and drug dispensing claims (allopurinol or colchicine) data for all Aotearoa New Zealand were used to estimate the prevalence of gout in 2009 (n = 4 295 296). As a comparison, we calculated gout prevalence using a large primary care dataset using general practitioner diagnosis and prescribing records (n = 555 313). For each of these datasets, we estimated the undercount through capture-recapture analysis using a Poisson regression model. A two-list model was used, which included covariates such as age, gender, ethnic groups and New Zealand deprivation quintiles.
The crude prevalence of diagnosed gout in the Aotearoa New Zealand population aged ≥ 20 years was 3.75%. The covariate-adjusted capture-recapture estimate of those not recorded but likely to have gout was 0.92%, giving an overall estimated prevalence of 4.67% (95% CI 4.49, 4.90%) for the population aged ≥ 20 years. This amounts to 80% of people with gout being identified by the algorithm for the Aotearoa New Zealand data-that is being recorded in either lists of dispensing of allopurinol or colchicine or hospital discharge. After capture-recapture, gout prevalence for all males aged ≥ 20 years was 7.3% and in older (≥ 65 years) Māori and Pacific men was >30%.
Capture-recapture analysis of administrative datasets provides a readily available method for estimating an aspect of unmet need in the population-in this instance potentially 20% of those with gout not being identified and treated specifically for this condition.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Allopurinol - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Colchicine - therapeutic use</subject><subject>Databases, Factual</subject><subject>Diseases of the osteoarticular system</subject><subject>Female</subject><subject>Gout - diagnosis</subject><subject>Gout - drug therapy</subject><subject>Gout - epidemiology</subject><subject>Gout Suppressants - therapeutic use</subject><subject>Humans</subject><subject>Inflammatory joint diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Middle Aged</subject><subject>Miscellaneous. Osteoarticular involvement in other diseases</subject><subject>New Zealand - epidemiology</subject><subject>Other metabolic disorders</subject><subject>Prevalence</subject><subject>Purines and pyrimidines (gout, hyperuricemia...)</subject><subject>White People</subject><issn>1462-0324</issn><issn>1462-0332</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpN0M1O3DAQB3CrKuoC7RNUqnypxGVZO3bshBtC5UNaqRzgHE2S8daQ2FvbqdhbX4IX7JNgtMuW04xGv5mR_oR85eyUs1oswi-cRkh-8KvN4hEjl_oDOeRSFXMmRPFx3xdyRo5ifGCMlVxUn8isKHQhyro8JE-3PqFLFgY6uRETdYg9NT7QlZ8S7S2snI82UnA9TQEhjZmf0Q7WaQr47-9zwF2fCQybV-sNBeogWZ8nFPrROhtTyIM_SHtIEDF9JgcGhohfdvWY3F_-uLu4ni9_Xt1cnC_nnVAszQUDLktdI6tUAWigkpVRnaiMYVxobFumFICSUiOKuuQtZKbKqq7rsmyVOCYn27vr4H9PGFMz2tjhMIBDP8WGMy215kJUmYot7YKPMaBp1sGOEDYZNa-RN-8jb7aR561vuwdTO2K_33nLOIPvOwCxg8EEcJ2N_52SXNSVFi_THZI-</recordid><startdate>20121001</startdate><enddate>20121001</enddate><creator>JACKSON, Gary</creator><creator>WRIGHT, Craig</creator><creator>THORNLEY, Simon</creator><creator>TAYLOR, William J</creator><creator>KARU, Leanne Te</creator><creator>GOW, Peter J</creator><creator>ARROLL, Bruce</creator><creator>GRIBBEN, Barry</creator><creator>DALBETH, Nicola</creator><creator>WINNARD, Doone</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121001</creationdate><title>Potential unmet need for gout diagnosis and treatment: capture―recapture analysis of a national administrative dataset</title><author>JACKSON, Gary ; WRIGHT, Craig ; THORNLEY, Simon ; TAYLOR, William J ; KARU, Leanne Te ; GOW, Peter J ; ARROLL, Bruce ; GRIBBEN, Barry ; DALBETH, Nicola ; WINNARD, Doone</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-30a14579e0862aefa848f6c38ff0137ebb066aa6447ee3951ba2ae65899955b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Allopurinol - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Colchicine - therapeutic use</topic><topic>Databases, Factual</topic><topic>Diseases of the osteoarticular system</topic><topic>Female</topic><topic>Gout - diagnosis</topic><topic>Gout - drug therapy</topic><topic>Gout - epidemiology</topic><topic>Gout Suppressants - therapeutic use</topic><topic>Humans</topic><topic>Inflammatory joint diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Middle Aged</topic><topic>Miscellaneous. Osteoarticular involvement in other diseases</topic><topic>New Zealand - epidemiology</topic><topic>Other metabolic disorders</topic><topic>Prevalence</topic><topic>Purines and pyrimidines (gout, hyperuricemia...)</topic><topic>White People</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>JACKSON, Gary</creatorcontrib><creatorcontrib>WRIGHT, Craig</creatorcontrib><creatorcontrib>THORNLEY, Simon</creatorcontrib><creatorcontrib>TAYLOR, William J</creatorcontrib><creatorcontrib>KARU, Leanne Te</creatorcontrib><creatorcontrib>GOW, Peter J</creatorcontrib><creatorcontrib>ARROLL, Bruce</creatorcontrib><creatorcontrib>GRIBBEN, Barry</creatorcontrib><creatorcontrib>DALBETH, Nicola</creatorcontrib><creatorcontrib>WINNARD, Doone</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>JACKSON, Gary</au><au>WRIGHT, Craig</au><au>THORNLEY, Simon</au><au>TAYLOR, William J</au><au>KARU, Leanne Te</au><au>GOW, Peter J</au><au>ARROLL, Bruce</au><au>GRIBBEN, Barry</au><au>DALBETH, Nicola</au><au>WINNARD, Doone</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potential unmet need for gout diagnosis and treatment: capture―recapture analysis of a national administrative dataset</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><addtitle>Rheumatology (Oxford)</addtitle><date>2012-10-01</date><risdate>2012</risdate><volume>51</volume><issue>10</issue><spage>1820</spage><epage>1824</epage><pages>1820-1824</pages><issn>1462-0324</issn><issn>1462-0332</issn><eissn>1462-0332</eissn><abstract>To estimate the degree of undercount of people diagnosed with gout in administrative datasets using capture-recapture methods.
Hospitalization and drug dispensing claims (allopurinol or colchicine) data for all Aotearoa New Zealand were used to estimate the prevalence of gout in 2009 (n = 4 295 296). As a comparison, we calculated gout prevalence using a large primary care dataset using general practitioner diagnosis and prescribing records (n = 555 313). For each of these datasets, we estimated the undercount through capture-recapture analysis using a Poisson regression model. A two-list model was used, which included covariates such as age, gender, ethnic groups and New Zealand deprivation quintiles.
The crude prevalence of diagnosed gout in the Aotearoa New Zealand population aged ≥ 20 years was 3.75%. The covariate-adjusted capture-recapture estimate of those not recorded but likely to have gout was 0.92%, giving an overall estimated prevalence of 4.67% (95% CI 4.49, 4.90%) for the population aged ≥ 20 years. This amounts to 80% of people with gout being identified by the algorithm for the Aotearoa New Zealand data-that is being recorded in either lists of dispensing of allopurinol or colchicine or hospital discharge. After capture-recapture, gout prevalence for all males aged ≥ 20 years was 7.3% and in older (≥ 65 years) Māori and Pacific men was >30%.
Capture-recapture analysis of administrative datasets provides a readily available method for estimating an aspect of unmet need in the population-in this instance potentially 20% of those with gout not being identified and treated specifically for this condition.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>22723595</pmid><doi>10.1093/rheumatology/kes147</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1462-0324 |
ispartof | Rheumatology (Oxford, England), 2012-10, Vol.51 (10), p.1820-1824 |
issn | 1462-0324 1462-0332 1462-0332 |
language | eng |
recordid | cdi_proquest_miscellaneous_1074771338 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Alma/SFX Local Collection |
subjects | Adult Aged Aged, 80 and over Allopurinol - therapeutic use Biological and medical sciences Colchicine - therapeutic use Databases, Factual Diseases of the osteoarticular system Female Gout - diagnosis Gout - drug therapy Gout - epidemiology Gout Suppressants - therapeutic use Humans Inflammatory joint diseases Male Medical sciences Metabolic diseases Middle Aged Miscellaneous. Osteoarticular involvement in other diseases New Zealand - epidemiology Other metabolic disorders Prevalence Purines and pyrimidines (gout, hyperuricemia...) White People |
title | Potential unmet need for gout diagnosis and treatment: capture―recapture analysis of a national administrative dataset |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T13%3A16%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potential%20unmet%20need%20for%20gout%20diagnosis%20and%20treatment:%20capture%E2%80%95recapture%20analysis%20of%20a%20national%20administrative%20dataset&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=JACKSON,%20Gary&rft.date=2012-10-01&rft.volume=51&rft.issue=10&rft.spage=1820&rft.epage=1824&rft.pages=1820-1824&rft.issn=1462-0324&rft.eissn=1462-0332&rft_id=info:doi/10.1093/rheumatology/kes147&rft_dat=%3Cproquest_cross%3E1074771338%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1074771338&rft_id=info:pmid/22723595&rfr_iscdi=true |